132 related articles for article (PubMed ID: 18187483)
1. Diffuse large B-cell lymphoma of the breast: a distinct entity?
Bierman PJ; Villanueva ML; Armitage JO
Ann Oncol; 2008 Feb; 19(2):201-2. PubMed ID: 18187483
[No Abstract] [Full Text] [Related]
2. Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group.
Ryan G; Martinelli G; Kuper-Hommel M; Tsang R; Pruneri G; Yuen K; Roos D; Lennard A; Devizzi L; Crabb S; Hossfeld D; Pratt G; Dell'Olio M; Choo SP; Bociek RG; Radford J; Lade S; Gianni AM; Zucca E; Cavalli F; Seymour JF;
Ann Oncol; 2008 Feb; 19(2):233-41. PubMed ID: 17932394
[TBL] [Abstract][Full Text] [Related]
3. Primary malignant non-Hodgkin's lymphoma of the breast: a study of seven cases and literature review.
Mouna B; Saber B; Tijani el H; Hind M; Amina T; Hassan E
World J Surg Oncol; 2012 Jul; 10():151. PubMed ID: 22800119
[TBL] [Abstract][Full Text] [Related]
4. [Prognosis analysis of primary breast diffuse large B cell lymphoma].
Zhu YH; Meng WJ; He LH; Jia YS; Tong ZS
Zhonghua Zhong Liu Za Zhi; 2019 Mar; 41(3):235-240. PubMed ID: 30917462
[No Abstract] [Full Text] [Related]
5. Principles of adjuvant therapy.
Dawson JW; Taylor I
Br J Hosp Med; 1995 Sep 20-Oct 3; 54(6):249-54. PubMed ID: 8542172
[TBL] [Abstract][Full Text] [Related]
6. Primary breast diffuse large B-cell lymphoma: treatment strategies and patterns of failure.
Ludmir EB; Milgrom SA; Pinnix CC; Gunther JR; Westin J; Oki Y; Fayad LE; Medeiros LJ; Dabaja BS; Nastoupil LJ
Leuk Lymphoma; 2018 Dec; 59(12):2896-2903. PubMed ID: 29697005
[TBL] [Abstract][Full Text] [Related]
7. Primary non-Hodgkin's lymphoma of the breast: retrospective analysis of prognosis and patterns of failure in two Australian centers.
Ryan GF; Roos DR; Seymour JF
Clin Lymphoma Myeloma; 2006 Jan; 6(4):337-41. PubMed ID: 16507213
[TBL] [Abstract][Full Text] [Related]
8. [Primary lymphoma of the breast].
Minullina RI; Afanas'eva ZA; Petrov SV; Ustimova KV; Mazitova FM
Vopr Onkol; 2010; 56(6):726-8. PubMed ID: 21395134
[No Abstract] [Full Text] [Related]
9. Prognostic influence of macrophages in patients with diffuse large B-cell lymphoma: a correlative study from a Nordic phase II trial.
Riihijärvi S; Fiskvik I; Taskinen M; Vajavaara H; Tikkala M; Yri O; Karjalainen-Lindsberg ML; Delabie J; Smeland E; Holte H; Leppä S
Haematologica; 2015 Feb; 100(2):238-45. PubMed ID: 25381134
[TBL] [Abstract][Full Text] [Related]
10. Local control of breast cancer: issues and answers.
Sledge GW
Clin Breast Cancer; 2002 Dec; 3(5):301. PubMed ID: 12533256
[No Abstract] [Full Text] [Related]
11. Localized primary non-Hodgkin lymphoma of the breast.
Ha CS; Dubey P; Goyal LK; Hess M; Cabanillas F; Cox JD
Am J Clin Oncol; 1998 Aug; 21(4):376-80. PubMed ID: 9708637
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy in stage III breast cancer.
Alassas M; Chu Q; Burton G; Ampil F; Mizell J; Li BD
Am Surg; 2005 Jun; 71(6):487-92. PubMed ID: 16044927
[TBL] [Abstract][Full Text] [Related]
13. The current role of sentinel node biopsy in the treatment of breast cancer.
Grube BJ; Giuliano AE
Adv Surg; 2004; 38():121-66. PubMed ID: 15515617
[No Abstract] [Full Text] [Related]
14. [Prognostic factors of metastatic breast cancer--2].
Brockmann B; Reitzig P; Dietzmann A; Cyganiak P
Z Arztl Fortbild (Jena); 1994 Apr; 88(4):305-9. PubMed ID: 8053233
[No Abstract] [Full Text] [Related]
15. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
Sanpaolo P; Barbieri V; Genovesi D
Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
[TBL] [Abstract][Full Text] [Related]
16. Alternative options for elderly patients with limited stage diffuse large B-cell lymphoma: R-chemotherapy vs. R-chemotherapy plus radiotherapy.
Ciammella P; Filippi AR; Simontacchi G; Buglione M; Furlan C; Spina M; Tucci A; Rigacci L; Iotti C; Vitolo U; Ricardi U; Merli F
Leuk Lymphoma; 2016 Nov; 57(11):2677-80. PubMed ID: 26926887
[No Abstract] [Full Text] [Related]
17. Risk factors for local recurrence in patients with invasive breast cancer and negative surgical margins of excision. Where are we and where are we going?
Schnitt SJ
Am J Clin Pathol; 2003 Oct; 120(4):485-8. PubMed ID: 14560560
[No Abstract] [Full Text] [Related]
18. Neoadjuvant chemotherapy for breast cancer-background for the indication of locoregional treatment.
Krug D; Baumann R; Budach W; Dunst J; Feyer P; Fietkau R; Haase W; Harms W; Hehr T; Piroth MD; Sedlmayer F; Souchon R; Wenz F; Sauer R;
Strahlenther Onkol; 2018 Sep; 194(9):797-805. PubMed ID: 29974132
[TBL] [Abstract][Full Text] [Related]
19. High grade primary breast lymphoma: is it a different clinical entity?
Fruchart C; Denoux Y; Chasle J; Peny AM; Boute V; Ollivier JM; Genot JY; Michels JJ
Breast Cancer Res Treat; 2005 Oct; 93(3):191-8. PubMed ID: 16172797
[TBL] [Abstract][Full Text] [Related]
20. Heart as the site of first relapse in diffuse large B-cell lymphoma.
Singhal M; Raina V; Medhi K; Gupta C; Reddy RM
Indian J Cancer; 2010; 47(2):220-2. PubMed ID: 20448391
[No Abstract] [Full Text] [Related]
[Next] [New Search]
